Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -46,487 | -41,911 | -36,811 | -2,050 | -4,069 |
| Depreciation Amortization | 54 | 40 | 27 | 13 | 11 |
| Accounts payable and accrued liabilities | -369 | -394 | 959 | -900 | 976 |
| Other Working Capital | -3,831 | -4,035 | -1,008 | -830 | 1,251 |
| Other Operating Activity | 32,210 | 31,680 | 29,952 | 902 | -940 |
| Operating Cash Flow | $-18,423 | $-14,620 | $-6,881 | $-2,865 | $-2,771 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -162 |
| Net Acquisitions | 3,582 | 3,582 | 3,583 | N/A | N/A |
| Investing Cash Flow | $3,582 | $3,582 | $3,583 | $N/A | $-162 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 66,956 | 24,274 | 24,108 | 45 | N/A |
| Other Financing Activity | -289 | 0 | 0 | 0 | 4,856 |
| Financing Cash Flow | $66,667 | $24,274 | $24,108 | $45 | $4,856 |
| Beginning Cash Position | 6,939 | 6,939 | 6,939 | 6,939 | 5,016 |
| End Cash Position | 58,765 | 20,175 | 27,749 | 4,119 | 6,939 |
| Net Cash Flow | $51,826 | $13,236 | $20,810 | $-2,820 | $1,923 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,423 | -14,620 | -6,881 | -2,865 | -2,771 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -162 |
| Free Cash Flow | -18,423 | -14,620 | -6,881 | -2,865 | -2,933 |